Browse All

Current Filters

CLEAR FILTER x

TITLE

Program Number:

Cilnidipine, a Novel N-Type Specific Calcium Channel Antagonist, Has Potent Activity at the Nav1.7 Sodium Channel, Which May Have Implications for Treatment of Certain Neuropathic Pain Conditions

Author:Sternlicht, Andrew   

Session Name:S23: Pain  

Topic:Pain  

Program Number:S23.003  

Author Institution:Aisa Pharma, Inc., Boston, MA